Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence

Long-term effectiveness of SERMs for preventing breast cancer

Genomic signatures and predictive biomarkers in breast cancer

Next generation PI3 kinase inhibition

Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry

Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers

The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study

Neurocognitive impact in adjuvant chemotherapy for breast cancer

Predicting late distant metastases in ER / HER2- breast cancer patients

Investigation of Ki67 biomarker

Results of a randomised phase 2 study of PD 0332991

Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer